Key result
Catheter-directed thrombolysis links to ~42% less major bleeding versus systemic thrombolysis in PE patients ≥65.
Why the study?
Reperfusion therapy is challenging in the elderly, and the safety of catheter-directed therapies has not been evaluated in specific vulnerable populations.
Do catheter-directed therapies reduce bleeding compared to classical reperfusion therapies in elderly and frail patients with pulmonary embolism?
Observational (n=980,245)
Yes
Do catheter-directed therapies reduce bleeding compared to classical reperfusion therapies in elderly and frail patients with pulmonary embolism?
In older patients with pulmonary embolism, catheter-directed therapies are associated with significantly lower rates of major bleeding compared to systemic thrombolysis and surgical embolectomy.
Answers are grounded in this paper and cite their sources.
May support CDT preference over ST to reduce bleeding in elderly PE; extends observational data but leaves open randomized confirmation.
BACKGROUND: Reperfusion therapy is challenging in the elderly. Catheter-directed therapies are an alternative for higher-risk pulmonary embolism (PE) patients if systemic thrombolysis (ST) is contraindicated or has failed. Their safety has not been evaluated in specific vulnerable populations. AIMS: We aimed to assess the safety of reperfusion therapies in elderly and frail patients in the real world. METHODS: In the US Nationwide Inpatient Sample from 2016 to 2020, we identified hospitalisations of patients ≥65 years with PE and defined a frailty subgroup using the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnosis indicator. We investigated reperfusion therapies (ST, catheter-directed thrombolysis [CDT], catheter-based thrombectomy [CBT], surgical embolectomy [SE]) and their associated safety outcomes (overall and major bleeding). RESULTS: Among 980,245 hospitalisations of patients ≥65 years with PE (28.0% frail), reperfusion therapies were used in 4.9% (17.6% among high-risk PE). ST utilisation remained stable, while the use of catheter-directed therapies increased from 1.7% in 2016 to 3.2% in 2020. Among all hospitalisations with reperfusion, CDT, compared to ST, was associated with reduced major bleeding (5.8% vs 12.2%, odds ratio [OR] 0.58, 95% confidence interval [CI]: 0.49-0.70); these results also applied to frail patients. CBT, compared to SE, was also associated with reduced major bleeding (11.0% vs 22.4%, OR 0.63, 95% CI: 0.43-0.91), but not among frail patients. These differences were particularly significant in patients with non-high-risk PE. Differences persisted for overall bleeding as well. CONCLUSIONS: Catheter-directed therapies may be a safer alternative to classical reperfusion therapies for elderly and frail patients with PE requiring reperfusion treatment.
No takes yet. Share an insight, caveat, or question.
Farmakis et al. (2023) conducted an observational in pulmonary embolism (n=980,245). Catheter-directed thrombolysis vs. Systemic thrombolysis was evaluated on major bleeding (OR 0.58, 95% CI 0.49-0.70). Catheter-directed thrombolysis, compared to systemic thrombolysis, was associated with reduced major bleeding in patients ≥65 years with pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: